Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04807231
Other study ID # PI2021_843_0044
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 11, 2021
Est. completion date March 2024

Study information

Verified date April 2023
Source Centre Hospitalier Universitaire, Amiens
Contact Marion SOYEZ, DR
Phone 03 22 08 71 02
Email Soyez.Marion@chu-amiens.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Currently, the gold standard to obtain bioavailable testosterone results is radioimmunoassay (RIA). However, this assay requires specific equipment. Giton in 2006 proposed an optimized calculation of the Vermeulen equation, the results of which seem to be well correlated with those obtained by RIA. The aim of this study is to determine if the bioavailable testosterone levels determined by both methods are similar in order to replace the usual RIA assay of bioavailable testosterone by this calculation.


Recruitment information / eligibility

Status Recruiting
Enrollment 270
Est. completion date March 2024
Est. primary completion date March 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Every men and women aged between 18 and 90 can be included Exclusion Criteria: - insufficient sample - sample not send for RIA

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Blood withdrawal
Blood withdrawal in order to perform a bioavailable testosterone RIA (Radio-Immuno Assay).

Locations

Country Name City State
France CHU Amiens Amiens

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concordance between RIA and calculated testosterone level Concordance between RIA and calculated testosterone level 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT05487794 - Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men With Erythrocytosis N/A
Not yet recruiting NCT02600650 - EndogenousTestosterone Response to a Testosterone Boosting Supplement N/A
Completed NCT03210558 - Study of Testosterone and Athlete Response Phase 2
Completed NCT05448378 - Evaluation of D-chiro-inositol Treatments N/A
Completed NCT02799277 - A Multinomial Process Model of Moral Judgment Phase 4
Withdrawn NCT04298840 - Influence of Creatine Monohydrate Supplementation on Androgens and Global Hair Assessments N/A
Active, not recruiting NCT02134470 - Diagnostic Relevance of Salivary Testosterone Concentrations in Doping Control. N/A
Completed NCT02434562 - Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation N/A